Press release
Cardiac Monitoring and Cardiac Rhythm Management Devices Market worth $26.8 billion by 2025 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Cardiac Monitoring and Cardiac Rhythm Management Devices Market By Product, CM (ECG (Holter Monitor), ILR, Event Monitor)), CRM ((Defibrillator (ICD) External (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User & Region – Global Forecast to 2025", published by MarketsandMarkets™, the Global Cardiac Monitoring Devices Market is projected to reach USD 26.8 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 4.0% from 2020 to 2025.Browse and in-depth TOC on "Cardiac Monitoring and Cardiac Rhythm Management Devices Market"
336 - Tables
40 - Figures
266 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55&utm_source=paidpr&utm_medium=openpr
The growth of this market is driven by the increasing prevalence of cardiovascular diseases; availability of reimbursement for CM & CRM devices; launch of innovative products by market players; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices.
"ECG Devices is expected to hold the largest share of the Cardiac Monitoring Devices Market in 2020"
On the basis of cardiac monitoring devices by type, the market is segmented into ECG devices, event monitors, implantable loop recorders (ILRs), cardiac output monitoring (COM) devices, mobile cardiac telemetry (MCT) devices, and smart ECG monitors. In 2019, the ECG devices segment accounted for the largest share of the market. The large share of this segment can be attributed to technological advancements such as the incorporation of advanced algorithms and workflow improvement features, such as simplified operations, touchscreen systems, portability, wireless features, and better connectivity with cardiovascular information systems (CVIS), electronic medical records (EMRs), and ECG management systems.
"Defibrillators is expected to hold the largest share of the cardiac rhythm management devices market in 2020"
On the basis of cardiac rhythm management devices by type, the market is segmented into defibrillators and pacemakers. In 2019, the defibrillators segment accounted for the largest market share. This segment is also projected to register the highest CAGR during the forecast period. Factors such as technological advancements in defibrillators, rising prevalence of CVD, and growing focus on providing public-access defibrillators are driving the growth of this market.
"Hospitals segment commanded the largest share of the cardiac monitoring and cardiac rhythm management devices market in 2020"
By end user, the cardiac rhythm management devices market is segmented into hospitals; clinics, cardiac centers, and ambulatory surgery centers (ASCs); and other end users. Hospitals accounted for the largest share of the market in 2019. The large share of this segment can be attributed to factors such as the increasing prevalence of CVD, the growing number of patient visits to hospitals for diagnosis, increasing number of cardiac implant procedures, and the availability of reimbursement for these procedures across developed markets
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=55&utm_source=paidpr&utm_medium=openpr
"North America commanded the largest share of the Cardiac Monitoring Devices Market in 2020."
On the basis of region, the Cardiac Rhythm Management Devices Market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America commanded the largest share of the market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.
The major players operating in this Cardiac Monitoring Devices Market are Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), MicroPort Scientific Corporation (China), Hill-Rom Holdings (US), Nihon Kohden (Japan), SCHILLER AG (Switzerland), BioTelemetry (US), BPL Medical Technologies (India), ACS Diagnostics (US), Shenzhen Mindray Bio-Medical Electronics (China), Lepu Medical Technology (China), Shree Pacetronix (India), OSYPKA (Germany), and BTL t(US), Alivecor, Inc. (US), Amiitalia (Italy), Bexen Cardio (Spain), Narang Medical Limited (India), MeTrax GmbH (Germany), and Progetti Srl (Italy).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Monitoring and Cardiac Rhythm Management Devices Market worth $26.8 billion by 2025 - Exclusive Report by MarketsandMarkets™ here
News-ID: 2221199 • Views: …
More Releases from MarketsandMarkets™
Feed Premix Market, Global Industry Size Forecast
The global feed premix market size is estimated to be valued at USD 24.3 billion in 2021 and is projected to reach a value of USD 32.9 billion by 2026, growing at a CAGR of 6.2% during the forecast period. The growth of this market is attributed to increasing awareness about feed quality, and the implementation of innovative animal husbandry practices to improve meat quality are the important drivers for…
Water-soluble Fertilizers Market is Expected to Grow $23.9 billion in 2028
According to a research report "Water-soluble Fertilizers Market by Type (Nitrogenous, Phosphatic, and Potassic), Mode of Application (Foliar and Fertigation), Form (Dry and Liquid), Crop Type (Field Crop, Horticulture Crops, Turf & ornaments) and Region - Global Forecast to 2028" published by MarketsandMarkets, the water-soluble fertilizers market is estimated at USD 18.3 billion in 2023 and is projected to reach USD 23.9 billion in 2028, at a CAGR of 5.5%.…

Population Health Management (PHM) Market worth $53.3 billion by 2027 - Leading …
Population Health Management (PHM) Market is projected to grow from USD 27.8 billion in 2022 to USD 53.3 billion by 2027, at a CAGR of 13.9% from 2022 to 2027, according to a new report by MarketsandMarkets™. The Growth in this market is driven by the opportunities offered by the emerging markets in healthcare. However, lack of data management, and interoperability issues are expected to challenge the growth of this…

Veterinary Pain Management Market worth $2.5 billion - Leading Key Players are B …
Veterinary Pain Management Market is projected to grow from USD 1.8 billion in 2022 to USD 2.5 billion by 2027, at a CAGR of 6.7% from 2022 to 2027, according to a new report by MarketsandMarkets™. The Pain is the physiological term to describe the chemical processes that are at work in the body that receive a stimulus, modify it, and transfer it to the brain for interpretation and reaction.…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…